Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

In the study, it was found that triptans did not increase risk in terms of episodic migraine transformation, but initially facilitated transformation in headache high

Hepatitis C patients with SVR achived by pegylated interferon + ribavirin (INF + RIB) treatment are followed and it is investigated whether cirrhosis, hepatocellular carcinoma

When the treated patients were divided into the peg-IFN treated group (n=15), and the NA-treated group (n=40), and analysed in terms of correlations of initial values;

When we compared the pre-treatment HRQoL scores of patients with CHC and controls, we determined statistically significantly lower physical functioning (p=0.006), physical

The rate of HBsAg clearance 3 years after treatment was 2% in HBeAg-positive patients and 5% in HBeAg- negative patients treated with Peg-IFN; the rate of HBsAg loss was 4.6%

To study level of vitamin D in Egyptian patients with chronic HCV infection and to investigate its correlation with activity and fibrosis scores of their liver biopsies, as well

Sustained virologic response rates obtained with peg-IFN+RBV treatment suggested that peg- IFN treatment should be used with current treatment combinations in prisoners infected

In the literature, when concurrent cases with HIV infection are excluded, development of acute pancreatitis is reported in 49 cases due to standard IFN alpha and 5 cases due